Alexis J. Pillsbury

Cnr Hawkesbury Road And Hainsworth Street
Westmead, NSW 2145, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

More than 10 years of Australia's AusVaxSafety (2014-2026): an adaptable model of a participant-powered active vaccine safety surveillance system.

More than 10 years of Australia's AusVaxSafety (2014-2026): an adaptable model of a participant-powered active vaccine safety surveillance system.

Journal: Vaccine
Published: June 15, 2026

The Live Attenuated Influenza Vaccine in Australia: An Additional Tool for Influenza Prevention.

The Live Attenuated Influenza Vaccine in Australia: An Additional Tool for Influenza Prevention.

Journal: The Medical journal of Australia
Published: February 06, 2026

Estimating current susceptibility to measles in Australia following sustained measles elimination.

Estimating current susceptibility to measles in Australia following sustained measles elimination.

Journal: Australian and New Zealand journal of public health
Published: October 21, 2025

Reduction in self-reported adverse events in Australian adults after change to national immunisation schedule from polysaccharide to conjugate pneumococcal vaccine, 2016-2022.

Reduction in self-reported adverse events in Australian adults after change to national immunisation schedule from polysaccharide to conjugate pneumococcal vaccine, 2016-2022.

Journal: Vaccine
Published: February 05, 2025

COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals.

COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals.

Journal: Vaccine
Published: January 29, 2024

Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis.

Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis.

Journal: Vaccine
Published: July 23, 2023

Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines.

Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines.

Journal: Vaccine
Published: August 04, 2022

Surveillance of adverse events following immunisation in Australia annual report, 2020.

Surveillance of adverse events following immunisation in Australia annual report, 2020.

Journal: Communicable diseases intelligence (2018)
Published: July 21, 2022

Australian vaccine preventable disease epidemiological review series: Pertussis, 2013-2018.

Australian vaccine preventable disease epidemiological review series: Pertussis, 2013-2018.

Journal: Communicable diseases intelligence (2018)
Published: January 30, 2022

The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.

The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.

Journal: The Medical journal of Australia
Published: November 20, 2021

Surveillance of adverse events following immunisation in Australia annual report, 2019.

Surveillance of adverse events following immunisation in Australia annual report, 2019.

Journal: Communicable diseases intelligence (2018)
Published: May 03, 2021

Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study.

Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study.

Journal: The Lancet. Child & adolescent health
Published: June 18, 2020
Showing 1-12 of 26

Last Updated: 09/26/2026